Morten Schou

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Adriaan A. Voors, Christiane E. Angermann, John R. Teerlink et al. · Nature Medicine · 2022 · 814 citations · Full text

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Scott D. Solomon, John J.V. McMurray, Muthiah Vaduganathan et al. · New England Journal of Medicine · 2024 · 530 citations · Full text

Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial

Anders Jorsal, Caroline Kistorp, Pernille Holmager et al. · European Journal of Heart Failure · 2016 · 521 citations · Full text

Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

Mikhail Kosiborod, Mark C. Petrie, Barry A. Borlaug et al. · New England Journal of Medicine · 2024 · 520 citations · Full text